.At this year’s Intense Biotech Summit in Boston, we overtook forerunners in the biotech field that have been actually identified as previous Strong 15 guest of honors..These private biotechs have brought in notable contributions to their industry, and their leading-edge job is shaping the future of the business.Fierce Biotech’s Gabrielle Masson sat down along with Liang Schweizer, Ph.D. owner, chairperson as well as chief executive officer of HiFiBiO Therapeutics Adam Friedman, M.D., Ph.D., CEO of Scorpion Therapies and Debanjan Radiation CEO of Synthekine.. In this particular full week’s episode of “The Leading Line,” these forerunners share their insights, adventures, and visions for the growing biotech garden.To get more information regarding the topics in this particular episode:.